Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Opens in a new tab or window Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of ...

The latest news from AAD 2025 focused on psoriasis including abstracts, features, and helpful conference information.

Opens in a new tab or window Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed ...

A study finds that 99% of dietary advice for psoriasis on Instagram is low-quality, often unsubstantiated and posted by ...

More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

A 27.6% increase occurred in the global incidence of pediatric psoriasis, with the largest increases among areas of lower sociodemographic indexes.

Late-breaking Oral Presentation Efficacy and Safety of a Highly Selective Oral TYK2 Inhibitor, ICP-488, in Patients with Moderate-to-Severe Plaque Psoriasis: A Phase II, Randomized, Double-blinded ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...